What 7 Analyst Ratings Have To Say About Unicycive Therapeutics
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 7 analysts have published their opinion on Unicycive Therapeutics (NASDAQ:UNCY) stock, with an average price target of $8.43, compared to its current price of $1.69. This represents a 35.15% decrease from the previous average price target of $13.00.
June 26, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
7 analysts have a bullish outlook on Unicycive Therapeutics (NASDAQ:UNCY) with an average price target of $8.43, a 35.15% decrease from the previous target of $13.00.
The article mentions that 7 analysts have published their opinion on Unicycive Therapeutics (NASDAQ:UNCY) stock over the past 3 months. The average price target of $8.43 implies an upside compared to the current price of $1.69. This bullish outlook from analysts could have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100